American Well (AMWL) UBS Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
UBS Global Healthcare Conference summary
14 Jan, 2026Strategic positioning and digital care evolution
Enables payers to offer members a unified digital care experience, improving ROI and access to a broad range of programs.
Reduces customer acquisition costs for clinical program vendors by integrating multiple programs into a single platform.
Supports providers in expanding digital engagement, increasing patient retention and market reach.
Acts as the digital glue connecting payers, providers, and point solutions, facilitating whole-person care.
Ongoing investment in consumer experience, data structure, care orchestration, and EHR integration remains a priority.
Market trends and business model transformation
Shift from fee-for-service to risk-based, value-driven models is accelerating, expected to dominate within 3-5 years.
Digital enablement infrastructure is essential for providers to participate effectively in risk-based care.
Most relationships are still fee-for-service, but a clear trend toward value-based models is evident.
The company has invested over $1 billion in building its digital infrastructure over two decades.
Financial strategy and revenue quality
Focus on growing subscription revenue, which is expected to become the majority of consolidated revenue.
Every investment is now evaluated for return, with funding only for initiatives that can validate ROI.
Subscription revenues are immediately profitable in their first year.
Emphasis on quality of revenue and reducing cash burn, with a goal of reaching cash flow positive in 2026.
New leadership expresses increased confidence in achieving break-even by 2026 after a month of internal review.
Latest events from American Well
- 2026 guidance targets $195–$205M revenue, EBITDA breakeven, and strong government contract momentum.AMWL
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Margins improved and losses narrowed, with positive cash flow targeted for Q4 2026.AMWL
Q4 202512 Feb 2026 - Director elections, auditor ratification, and reverse stock split proposal advanced to vote.AMWL
AGM 20243 Feb 2026 - Q2 revenue rose to $62.8M, losses narrowed, and 2024 EBITDA guidance improved.AMWL
Q2 20242 Feb 2026 - Converge platform drives digital-first care, boosting margins and setting up profitability by 2026.AMWL
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 revenue was $61M, net loss narrowed, and cost actions support 2026 cash flow goals.AMWL
Q3 202417 Jan 2026 - Major government SaaS rollout and platform growth drive optimism for multi-year expansion.AMWL
TD Cowen 45th Annual Healthcare Conference18 Dec 2025 - Improved margins and subscription growth support a return to growth and positive cash flow by 2026.AMWL
Q4 20242 Dec 2025 - Shareholders to vote on directors, auditor, and executive pay amid strong governance and ESG focus.AMWL
Proxy Filing1 Dec 2025